American Century Companies’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Buy |
|
|||||
|
2025
Q1 | $487K | Buy |
|
|||||
|
2024
Q4 | $486K | Buy |
|
|||||
|
2024
Q3 | $480K | Buy |
|
|||||
|
2024
Q2 | $414K | Buy |
|
|||||
|
2024
Q1 | $441K | Buy |
|
|||||
|
2023
Q4 | $240K | Buy |
|
|||||
|
2023
Q3 | $168K | Buy |
|
|||||
|
2023
Q2 | $129K | Buy |
|
|||||
|
2023
Q1 | $62.2K | Buy |
|
|||||
|
2022
Q4 | $83.5K | Buy |
|
|||||
|
2022
Q3 | $89K | Buy |
|
|||||
|
2022
Q2 | $90K | Sell |
|
|||||
|
2022
Q1 | $242K | Sell |
|
|||||
|
2021
Q4 | $527K | Sell |
|
|||||
|
2021
Q3 | $2.39M | Buy |
|